A phase III randomized study of paclitaxel and trastuzumab versus paclitaxel alone for early stage, ER and PR receptor negative and HER2-positive breast cancer as adjuvant treatmen... von Singhal, M.K., Kapoor, A., Narayan, S., Maharia, S., Nirban, R.K., Beniwal, S.K., Kumar, H.S.

Volltext

617PDA PHASE III TRIAL COMPARING FOLFIRINOX VERSUS GEMCITABINE FOR METASTATIC PANCREATIC CANCER von Singhal, M.K., Kapoor, A., Bagri, P.K., Narayan, S., Singh, D., Nirban, R.K., Singh, G., Maharia, S., Kumari, P., Jakhar, S.L., Beniwal, S., Sharma, N., Harsh, K., Kumar, H.S., Sharma, A., Bardia, M.

Volltext

Pros and Cons of Adding of Neoadjuvant Chemotherapy to Standard Concurrent Chemoradiotherapy in Cervical Cancer: a Regional Cancer Center Experience von Narayan, S., Kapoor, A., Bagri, P.K., Singhal, M.K., Sharma, R., Nirban, R.K., Singh, D., Maharia, S., Singh, G., Kumari, P., Harsh, K., Sharma, N., Jakhar, S.L., Beniwal, S., Kumar, H.S., Sharma, A., Bardia, M.

Volltext

A Phase III Trial Comparing Folfirinox Versus Gemcitabine for Metastatic Pancreatic Cancer von Singhal, M.K., Kapoor, A., Bagri, P.K., Narayan, S., Singh, D., Nirban, R.K., Singh, G., Maharia, S., Kumari, P., Jakhar, S.L., Beniwal, S., Sharma, N., Harsh, K., Kumar, H.S., Sharma, A., Bardia, M.

Volltext

Estimates of heritability for growth and wool traits in Marwari sheep at arid region of Rajasthan von Nirban, L.K, Joshi, R.K, Narula, H.K, Singh, H, Bhakar, S

Volltext